Checkpoint inhibitors: Better outcomes among advanced cutaneous head and neck melanoma patients

OBJECTIVE: The aim of this study was to investigate if the treatment outcomes of checkpoint inhibitors (CPI) in patients with advanced-stage skin head and neck melanoma (HNM) differs from outcomes in patients with non-HNM. DESIGN: A retrospective cohort study of patients with unresectable AJCC stage...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirshoren, Nir, Yoeli, Roni, Cohen, Jonathan E., Weinberger, Jeffrey M., Kaplan, Nadia, Merims, Sharon, Peretz, Tamar, Lotem, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153888/
https://www.ncbi.nlm.nih.gov/pubmed/32282861
http://dx.doi.org/10.1371/journal.pone.0231038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153888/
https://www.ncbi.nlm.nih.gov/pubmed/32282861
http://dx.doi.org/10.1371/journal.pone.0231038

Ejemplares similares